|
Session 152
Poster Abstracts
Dyslipidemia: Role of ART and Interventions for Management
Monday, 1-4 pm
Room: Hall B |
| 929 |
Fasted Lipid Changes after Administration of Maraviroc or Efavirenz in Combination with Zidovudine and Lamivudine for 48 weeks to Treatment-naïve HIV-infected Patients
E DeJesus*1, S Walmsley2, C Cohen3, D Cooper4, B Hirschel5, J Goodrich6, H Valdez7, J Heera6, N Rajicic6, and H Mayer6
1Orlando Immunology Ctr, FL, US; 2Univ of Toronto, Canada; 3Community Res Initiative of New England, Boston, MA, US; 4Univ of New South Wales, Australia; 5Hosp Univ of Geneva, Switzerland; 6Pfizer Global R&D, New London, CT, US; and 7Pfizer Inc, New York, NY, US |
| 930 |
Plasma Exposure of 100 mg Once and Twice Daily Decreases HDL and CD36 Expression but Only Twice-daily Dosing Increases Triglycerides: Potential Effect of RTV on Cardiovascular Disease
Marta Boffito*1, S Collot-Teixeira2, F De Lorenzo3, L Waters1, C Fletcher1, D Back4, S Mandalia1, A Pozniak1, J McGregor2, and B Gazzard1
1St Stephen`s Ctr, London, UK; 2King`s Coll London, UK; 3Chelsea and Westminster Hosp NHS Fndn Trust, London, UK; and 4Univ of Liverpool, UK |
| 931 |
The Effect of Hepatitis C Infection on Metabolic Parameters following Initial Therapy of HIV-infected Subjects with Nucleoside +/- NNRTI Regimens
Cecilia Shikuma*1, H Ribaudo2, E Zheng2, M Glesby3, W Meyer4, K Tashima5, B Bastow6, D Kuritzkes7, R Gulick3, and AIDS Clinical Trials Group A5095 Study Team
1Univ of Hawaii, Honolulu, US; 2Harvard Sch of Publ Hlth, Boston, MA, US; 3Weill Med Coll of Cornell Univ, New York, NY, US; 4Quest Diagnostics, Baltimore, MD, US; 5Brown Univ, Providence, RI, US; 6Social & Sci Systems, Silver Spring, MD, US; and 7Brigham and Women`s Hosp, Boston, MA, US |
| 932 |
Changes in Markers of Atherogenic Dyslipidemia, Inflammation, and Platelet Activation with Treatment with Pravastatin, Fenofibrate, or the Combination: Results from the ACTG A5087 Team
Carl Fichtenbaum*1, T M Yeh2, S Evans2, J Aberg3, and AIDS Clinical Trials Group
1Univ of Cincinnati Coll of Med, OH, US; 2Harvard Sch of Publ Hlth, Cambridge, MA, US; and 3New York Univ Sch of Med, NY, US |
| 933 |
ART Exposure and Insulin Resistance in the Women’s Interagency HIV Study
Phyllis Tien*1, M Schneider2, S Cole2, A Levine3, M Cohen4, J DeHovitz5, M Young6, and J Justman7
1VAMC and Univ of California, San Francisco, US; 2Johns Hopkins Univ Bloomberg Sch of Publ Hlth, Baltimore, MD, US; 3Univ of Southern California, Los Angeles, US; 4CORE Ctr and Storger Hosp, Chicago, IL, US; 5State Univ of NewYork Downstate Med Ctr, Brooklyn, US; 6Georgetown Univ Med Ctr, Washington, DC, US; and 7Columbia Univ, New York, NY, US |
| 934 |
Differences in Lopinavir Plasma Concentrations Comparing Kaletra Film Coated Tablets and Soft Gelatin Capsules Translate into Distinct Lipid Abnormalities
Judit Morello*, S Rodriguez-Novoa, F Blanco, A Rubio, I Jimenez-Nacher, and V Soriano
Hosp Carlos III, Madrid, Spain |
|
